Cardiol Therapeutics (TSE:CRDL) Shares Down 5% – Time to Sell?

Cardiol Therapeutics Inc. (TSE:CRDL) shares traded down 5% during mid-day trading on Tuesday . The company traded as low as C$1.51 and last traded at C$1.52. 86,322 shares traded hands during mid-day trading, an increase of 35% from the average session volume of 64,026 shares. The stock had previously closed at C$1.60.

Cardiol Therapeutics Stock Up 2.1 %

The firm has a 50-day simple moving average of C$1.76 and a 200 day simple moving average of C$2.17. The stock has a market capitalization of C$120.32 million, a P/E ratio of -2.85 and a beta of 0.70. The company has a debt-to-equity ratio of 1.59, a current ratio of 2.49 and a quick ratio of 6.84.

Cardiol Therapeutics Company Profile

Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis.